Keywords: tovaxin, trial, completes, patient, enrollment, texas, usa-based

Tovaxin trial completes patient enrollment

Article | 28 May 2007

Print This

Texas, USA-based cell-therapy developer Opexa Therapeutics says it has completed patient enrollment in a Phase IIb study of Tovaxin, its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in